ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Mark E. Robson
Matched on ORCID iD 0000-0002-3109-1692; OpenAlex author ID A5045514288. Sources: ClinicalTrials.gov.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2006: 1 trial · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper
Papers 3
- Identification of germline genetic mutations in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.29664↗
- Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. Last author DOI 10.1002/cncr.26191↗
- An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. Co-author DOI 10.1634/theoncologist.2011-0185↗
Trials 1
- Clinical Outcomes in Hereditary Cancer Principal investigator NCT00580021↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zsofia Kinga Stadler · 3 shared papers, 2011–2015 · strength 0.09
- Paper Identification of germline genetic mutations in patients with pancreatic cancer. DOI 10.1002/cncr.29664↗
- Paper Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. DOI 10.1002/cncr.26191↗
- Paper An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment im… DOI 10.1634/theoncologist.2011-0185↗
- Erin E. Salo‐Mullen · 3 shared papers, 2011–2015 · strength 0.09
- Paper Identification of germline genetic mutations in patients with pancreatic cancer. DOI 10.1002/cncr.29664↗
- Paper Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. DOI 10.1002/cncr.26191↗
- Paper An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment im… DOI 10.1634/theoncologist.2011-0185↗
- David Paul Kelsen · 3 shared papers, 2011–2015 · strength 0.09
- Paper Identification of germline genetic mutations in patients with pancreatic cancer. DOI 10.1002/cncr.29664↗
- Paper Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. DOI 10.1002/cncr.26191↗
- Paper An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment im… DOI 10.1634/theoncologist.2011-0185↗
- Robert C. Kurtz · 3 shared papers, 2011–2015 · strength 0.09
- Paper Identification of germline genetic mutations in patients with pancreatic cancer. DOI 10.1002/cncr.29664↗
- Paper Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. DOI 10.1002/cncr.26191↗
- Paper An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment im… DOI 10.1634/theoncologist.2011-0185↗
- Eileen Mary O'Reilly · 2 shared papers, 2011–2015 · strength 0.06
- Maeve Aine Lowery · 2 shared papers, 2011–2015 · strength 0.06
- Kenneth H. Yu · 2 shared papers, 2011–2015 · strength 0.06
- Amethyst Saldia · 1 shared paper, 2015 · strength 0.04
- Andrew S. Epstein · 1 shared paper, 2015 · strength 0.04
- Diane L. Reidy‐Lagunes · 1 shared paper, 2015 · strength 0.04
- Leonard B. Saltz · 1 shared paper, 2015 · strength 0.04
- Emmy Ludwig · 1 shared paper, 2011 · strength 0.02
- Peter J. Allen · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.